Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Nervenarzt ; 84(10): 1183-9, 2013 Oct.
Article in German | MEDLINE | ID: mdl-24036701

ABSTRACT

The beta-antagonistic agent propranolol is increasingly being used in clinical trials for the prophylaxis and treatment of post-traumatic stress disorder (PTSD). This article discusses the evidence for the effectiveness of propranolol in the prophylaxis and treatment of PTSD and the ethical implications of research on these treatment approaches. The efficacy of a prophylactic or therapeutic use could not be shown during the last decade. Both treatment approaches raise ethical questions that should already be addressed during the clinical trials.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Ethics, Medical , Evidence-Based Medicine/ethics , Propranolol/therapeutic use , Stress Disorders, Post-Traumatic/drug therapy , Stress Disorders, Post-Traumatic/prevention & control , Adrenergic beta-Antagonists/adverse effects , Animals , Arousal/drug effects , Combined Modality Therapy , Disease Models, Animal , Humans , Informed Consent , Memory, Episodic , Propranolol/adverse effects , Psychotherapy , Randomized Controlled Trials as Topic , Risk Assessment , Stress Disorders, Post-Traumatic/psychology
SELECTION OF CITATIONS
SEARCH DETAIL